Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 454

PDF Downloaded: 314


Get Permission Medatwal, Singhvi, Medatwal, and Garg: Treatment management of congenital nasolacrimal duct atresia: A review article


Introduction

A atresia of nasolacrimal duct is a common condition in newborns and infants, clinically it present in the form of excessive tears, means epiphora1 the prevalence is 05% to 20% in children according to epidemiological studies report.2, 3 MacEwen et al. found too much lacrimation in 95% of neonatal age group and approximately 20% after the neonatal period of infants.3 The point where the nasolacrimal duct enters into the nose is a place of obstruction[valve of Hasner] and the causes are presence of membrane, bone defect and inferior meatus stenosis.4, 5 The nasolacrimal apparatus and drainage system develop in the last three months of pregnancy which causes higher percentage of excessive lacrimation in premature baby.6 It presents clinically in the form of ocular mattering and tearing. Other causes of epiphora are infantile glaucoma, foreign body, corneal infections7 and conjunctival bacterial infection1, 8 should be ruled out. A percentage of anisometropic amblyopia found in children with CLND obstruction (10–12%) is high.7, 9 Maximum number of congenital NLD atresia cases are naturally resolve in their first year of life10, 11, 12, 13, 14 and, in some cases, this disorder may present after the one year of age, so, more update protocol for the treatment management of congenital nasolacrimal duct atresia are needed.

Observation

The conservative approach is wait and watch policy with proper lacrimal sac massage, and use of antibiotic eye drops topically when a bacterial infection occurs. So many studies shows by the age of 13 month spontaneous resolution from 32% to 95%.15, 11, 12, 13, 14 Most of the studies explain spontaneous resolution rates are 80–90% in the first three months, 68–75% in second and finally 36–57% in the third3, 12, 14 trimester of life. Nelson et al. described resolution rate of 93% with conservative management in children aged 8 months or less.10

Similarly, Noda et al. Japanese infants are managed with a conservative approach up to the age of nine months.14 But, self resolution of atresia still occurred after the first year of life;11, 16 in continuation Young et al. Stated that atresia resolve between 1 to 2 year of life in 44% of the children.17 Bilateral atresia reported in 14–33.8% cases, which also resolved within the 3 months of age.18

Massage of lacrimal sac

The sac massage is a widely accepted conservative treatment method. In continuation of A randomized prospective trial of Kushner shows the efficacy of a simple massage in relation with no massage at all.19 Though some studies have questioned the clinical effect of this method,20, 21 a new recent study of Stolovitch et al. showed a success ratio of 56% in children upto 2 months, 46% in children between 2 to 6 month, and 28% in children above 6 months of age.22

IN continuation, a recent study gives a statistical difference of resolution rate in infants with lacrimal sac massage and those did not received massage (96.2% vs. 77.7%, p = 0.001.23 These results shows the Crigler maneuver [lacrimal sac massage] importance. Ultimately, a simple observation with correct massage of sac is the first-line treatment in congenital NLD atresia up to the age of one year. The antibiotic role is not established in noninfective CNLD atresia. Several studies already states that there is no advantage of antibiotic drops with conservative treatement in simple atresia.12, 24, 25, 26 Moreover, for controlling the local spread of an infection an use of antibiotic drop may be helpful.27, 28

In conclusion, most of the articles shows that the antibiotic therapy was used only when the clinical evidence of infection was present. Invasive treatment is also there in the form of NLD dilatation and surgery. The first-line of invasive treatment consists of irrigation with probing and other methods include repeated probing, silicone tube intubation and balloon dilatation of the lacrimal apparatus. The most common surgical treatment is probing in the children of congenital nasolacrimal duct atresia.16, 17, 29, 30, 31, 32, 33, 34 Evidence shows that resolution rate of congenital nasolacrimal duct atresia in children below 12 months who underwent primary early probing under topical anesthesia, ranges from 75% to 89%, in comparison to children who are older than 12 months. It means a success rate is more in primary late probing in comparison with early probing35, 36, 37, 38. In continuation, several articles claims better results in affected children above one year.39, 40, 41 In sequence, Rajabi et al. claim rewarding results in 75.8%, specifically 85% in 2 to 3 years, 63% in 3 to 4 years, and 50% in 4 to 5 years of age group.42 Napier et al. claim A 76% of success rate in primary probing as a first-line intervention having no relation of gender, age and type of obstruction. 43.

The conservative treatment which is safe and effective in the most of the children and comparable results found in older than 12 months by late probing, so it acts as a reasonable second-line treatment strategy.

The clinical efficacy of other surgical interventions has been studied by Several studies. The placement of a silicone tube stent in canaliculi by nasolacrimal intubation in one or both nasal canaliculi is method of nasolacrimal intubation 14, 44 generally tubes are left in situ for a period of 2 to 6 months.

The nasolacrimal intubation having good results with some complications, but still, it should be regarded more in effective second-line management strategy.45, 18, 46, 47

For reducing the probing-induced complications48, 49 the nasolacrimal duct dilate by the balloon catheter inflation.

If all these procedures have no results, means there are some problem in the form of bony obstruction, dacryocystitis, and dacryocystocele. Dacryocystorhinostomy is surgical procedure of choice50, 51 but recent endoscopic technique having better success rate and decreased postoperative complications by external surgical approach.52, 53

Conclusions

A relatively common condition in the pediatric population (5–20% is Congenital nasolcrimal duct atresia.

Two third of children having congenital NLD atresia below the one year of age can be managed successfully by conservative medical treatment with high success rate.

Training of parents should be proper for performing a correct lacrimal sac massage [Crigler maneuver] 4-5 times a day which increases the spontaneous resolution chances. Due to the possibility of spontaneous resolution after first year, a invasive treatment should be performed after the age of 15 to 18 months age.

Conversely, due to lack of proof in support of antibiotic therapy in congenital nasolacrimal duct atresia treatment so antibiotics should be restricted only for the infective cases.

Early probing and late probing having comparable results, so it can be postponed for first year of life and considered for better results within 2-3 years of age. More specifically the first-line invasive treatment is probing. For that the conservative approach for treatment of congenital nasolacrimal duct atresia should be postponed as long as possible and invasive method should be considered when the conservative treatment method fails. In some cases where the probing methods fails second line of surgical management can be opted such as balloon catheter intubation and endoscopic dacryocystorhinostomy. These second line method are advanced surgical method.

Source of Funding

None.

Conflict of Interest

None.

References

1 

BM Schnall Pediatric nasolacrimal duct obstructionCurr Opin Ophthalmol20132454214

2 

D Sevel Development and congenital abnormalities of the nasolacrimal apparatusJ Pediatr Ophthalmol Strabismus1981185139

3 

CJ Macewen JD Young Epiphora during the first year of lifeEye (Lond)19915Pt 5596600

4 

EE Moscato JP Kelly A Weiss Developmental anatomy of the nasolacrimal duct: implications for congenital obstructionOphthalmology20101171224304

5 

AH Weiss F Baran J Kelly Congenital nasolacrimal duct obstruction: Delineation of anatomic abnormalities with 3-dimensional reconstructionArch Ophthalmol201213078428

6 

SHT Lorena JAF Silva MJ Scarpi Congenital nasolacrimal duct obstruction in premature childrenJ Pediatr Ophthalmol Strabismus201350423944

7 

NS Matta EL Singman DI Silbert Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstructionJ AAPOS20101453868

8 

MB Kashkouli A Sadeghipour R Kaghazkanani A Bayat F Pakdel GH Aghai Pathogenesis of primary acquired nasolacrimal duct obstructionOrbit2010291115

9 

NS Matta DI Silbert High prevalence of amblyopia risk factors in preverbal children with nasolacrimal duct obstructionJ AAPOS20111543502

10 

LR Nelson JH Calhoun H Menduke Medical management of congenital nasolacrimal duct obstructionOphthalmology1985929118790

11 

P Nucci C Capoferri R Alfarano R Brancato Conservative management of congenital nasolacrimal duct obstructionJ Pediatr Ophthalmol Strabismus19892613943

12 

H Kakizaki Y Takahashi S Kinoshita K Shiraki M Iwaki The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of ageClin Ophthalmol2008222914

13 

HW Price DacryostenosisJ Pediatr19473033025

14 

TO Paul Medical management of congenital nasolacrimal duct obstructionJ Pediatr Ophthalmol Strabismus19852226870

15 

RA Petersen RM Robb The natural course of congenital obstruction of the nasolacrimal ductJ Pediatr Ophthalmol Strabismus197815424650

16 

SA Schellini SCF Ribeiro E Jaqueta CR Padovani CR Padovani Spontaneous resolution in congenital nasolacrimal obstruction after 12 monthsSemin Ophthalmol2007222714

17 

JD Young CJ Macewen SA Ogston Congenital nasolacrimal duct obstruction in the second year of life: A multicentre trial of managementEye (Lond)199610 Pt 448591

18 

MX Repka BM Melia RW Beck CS Atkinson DL Chandler J Holmes Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of ageJ AAPOS200812544550

19 

BJ Kushner Congenital nasolacrimal system obstructionArch Ophthalmol19731004597600

20 

BA Weil Application of clinical technics and surgery in the diagnosis and treatment of lacrimal apparatus pathologyArch Oftalmol B Aires1967424738

21 

LT Jones Anatomy of the tear systemInt Ophthalmol Clin197313322

22 

C Stolovitch A Michaeli Hydrostatic pressure as an office procedure for congenital nasolacrimal duct obstructionJ AAPOS200610326972

23 

O Karti E Karahan D Acan T Kusbeci The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massageInt Ophthalmol20163668459

24 

RM Robb Congenital nasolacrimal duct obstructionOphthalmol Clin North Am20011434436

25 

YS Kim SC Moon KW Yoo Congenital nasolacrimal duct obstruction: Irrigation or probing?Korean J Ophthalmol2000142906

26 

RA Welham SM Hughes Lacrimal surgery in childrenAm J Ophthalmol19859912734

27 

CJ Macewen MG Phillips JD Young Value of bacterial culturing in the course of congenital nasolacrimal duct (NLD) obstructionJ Pediatr Ophthalmol Strabismus199431424650

28 

JD Young CJ Macewen Managing congenital lacrimal obstruction in general practiceBMJ199731571032936

29 

C Petris D Liu Probing for congenital nasolacrimal duct obstructionCochrane Database Syst Rev201720177CD011109

30 

JD Baker Treatment of congenital nasolacrimal system obstructionJ Pediatr Ophthalmol Strabismus1985221346

31 

D Stager JD Baker T Frey DR Weakley EE Birch Office probing of congenital nasolacrimal duct obstructionOphthalmic Surg19922374824

32 

RM Robb Probing and irrigation for congenital nasolacrimal duct obstructionArch Ophthalmol198610433789

33 

TO Paul R Shepherd Congenital nasolacrimal duct obstruction: Natural history and the timing of optimal interventionJ Pediatr Ophthalmol Strabismus19943163627

34 

J Kassoff DR Meyer Early office-based vs. late hospital-based nasolacrimal duct probing. A clinical decision analysisArch Ophthalmol19951139116871

35 

K Hayashi N Katori H Komatsu K Ohno-Matsui Spontaneous resolving rate of congenital nasolacrimal duct obstruction and success rate of late probing after age 18 months: Historical cohort studyNippon Ganka Gakkai Zasshi20141182917

36 

LB Nelson Late probing success for congenital nasolacrimal duct obstructionJ Pediatr Ophthalmol Strabismus200845138

37 

R Maheshwari S Maheshawri Late probing for congenital nasolacrimal duct obstructionJ Coll Physicians Surg Pak2007171413

38 

S Arora K Koushan J Harvey Success rates of primary probing for congenital nasolacrimal obstruction in childrenJ Aapos2012161736

39 

JA Katowitz MG Welsh Timing of initial probing and irrigation in congenital nasolacrimal duct obstructionOphthalmology1987946698705

40 

MB Kashkouli A Kassaee Z Tabatabaee Initial nasolacrimal duct probing in children under age 5: Cure rate and factors affecting successJ AAPOS2002663603

41 

MB Kashkouli B Beigi MM Parvaresh A Kassaee Z Tabatabaee Late and very late initial probing for congenital nasolacrimal duct obstruction: What is the cause of failure?Br J Ophthalmol200387911513

42 

MT Rajabi Y Abrishami SS Hosseini SZ Tabatabaee MB Rajabi JJ Hurwitz Success rate of late primary probing in congenital nasolacrimal duct obstructionJ Pediatr Ophthalmol Strabismus20145163602

43 

ML Napier DJ Armstrong SF Mcloone EM Mcloone Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment AlgorithmsJ Pediatr Ophthalmol Strabismus201653528591

44 

SM Goldstein JB Goldstein J Katowitz Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probingOphthalmic Plast Reconstr Surg20042053527

45 

MK Kapadia SK Freitag JJ Woog Evaluation and management of congenital nasolacrimal duct obstructionOtolaryngol Clin North Am200639595977

46 

JE Marr A Drake-Lee HE Willshaw Management of childhood epiphoraBr J Ophthalmol200589112326

47 

H Al-Hussain A M Nasr Silastic intubation in congenital nasolacrimal duct obstruction: A study of 129 eyesOphthal. Plast. Recons199393237

48 

DR Casady DR Meyer JW Simon GO Stasior JL Zobal-Ratner Stepwise treatment paradigm for congenital nasolacrimal duct obstructionOphthalmic Plast Reconstr Surg20062242437

49 

S Tao DR Meyer JW Simon J Zobal-Ratner Success of balloon catheter dilatation as a primary or secondary procedure for congenital nasolacrimal duct obstructionOphthalmology200210911210811

50 

TS Nowinski JC Flanagan J Mauriello Pediatric dacryocystorhinostomyArch Ophthalmol1985103812268

51 

HG Struck R Weidlich Indications and prognosis of dacryocystorhinostomy in childhood. A clinical study 1970-2000Ophthalmologe19709865603

52 

F Celenk S Mumbuc C Durucu ZA Karatas I Aytac E Baysal Pediatric endonasal endoscopic dacryocystorhinostomyInt J Pediatr Otorhinolaryngol2013778125962

53 

CE deSouza J Nisar RA deSouza Pediatric endoscopic dacryocystorhinostomyOtolaryngol Head Neck Surg201214723357



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

485-488


Authors Details

Anurag Medatwal*, Puneet Singhvi, Ritu Medatwal, Manoj Garg


Article History

Received : 14-11-2023

Accepted : 25-11-2023


Article Metrics


View Article As

 


Downlaod Files